Argenta Discovery is a respiratory-focused pharmaceutical R&D company that develops pipeline of novel therapies to treat serious diseases such as chronic obstructive pulmonary disease (COPD), severe steroid-insensitive asthma, allergic asthma and cystic fibrosis (CF). Argenta intends to progress its program through phase 2a proof of concept clinical trials before partnering. Argenta Discovery also has a successful contract research business and offers expertise in medicinal chemistry, assay development and screening, ADMET/PK (absorption, distribution, metabolism, excretion, toxicology/pharmacokinetics), computer-aided drug design (CADD) and respiratory profiling offering to pharmaceutical and biotechnology companies.